PBS新药将帮助降低一半黑色素瘤死亡率

Acral lentiginous melanoma of the sole, level 1.

Acral lentiginous melanoma of the sole, level 1. Source: Getty Images

药品福利计划(Pharmaceutical Benefits Scheme) PBS 新增一种新药物,可将澳大利亚的黑色素瘤三期癌症患者的死亡率降低一半。


澳大利亚是全球黑色素瘤情况最严重的国家,患者人数是世界平均水平的11倍。预计,今年全国将有超过1万5,000例黑色素瘤患者被确诊,其中1700多人将失去生命,也就是每5小时就有1名黑色素瘤患者失去生命。

澳大利亚黑色素瘤研究所(The Melanoma Institute of Australia)的Georgina Long教授说:“这是PBS上列出的治疗黑色素瘤的第一种药物,这些药物能靶向癌细胞 B-RAF突变,杀死黑色素瘤癌细胞。”

 Alfred Health肿瘤学家Andrew Haydon博士表示:“这个靶向药物能够将黑色素瘤的复发减少一半,大大提高患者的存活率。”

临床试验表明,有20%的患者使用会出现呕吐和疲倦等药物副作用,但黑素瘤复发的风险降低了50%。

READ MORE


Share

News

Sign up now for the latest news from Australia and around the world direct to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Download our apps
SBS Audio
SBS On Demand

Listen to our podcasts
Independent news and stories connecting you to life in Australia and Mandarin-speaking Australians.
Understand the quirky parts of Aussie life.
Get the latest with our exclusive in-language podcasts on your favourite podcast apps.

Watch on SBS
Simplified Chinese Collection

Simplified Chinese Collection

Watch onDemand
PBS新药将帮助降低一半黑色素瘤死亡率 | SBS Chinese